Free Trial

Uniphar (LON:UPR) Sets New 52-Week High - What's Next?

Uniphar logo with Medical background

Uniphar plc (LON:UPR - Get Free Report)'s stock price reached a new 52-week high on Monday . The company traded as high as GBX 346 ($4.64) and last traded at GBX 346 ($4.64), with a volume of 100001 shares changing hands. The stock had previously closed at GBX 345.40 ($4.64).

Wall Street Analyst Weigh In

Separately, Shore Capital restated a "buy" rating on shares of Uniphar in a research report on Thursday, May 29th.

Check Out Our Latest Research Report on UPR

Uniphar Stock Up 0.2%

The firm's 50-day moving average price is GBX 279.78 and its 200 day moving average price is GBX 227.10. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The company has a market capitalization of £1.08 billion, a price-to-earnings ratio of 24.06 and a beta of 0.75.

Uniphar Company Profile

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Uniphar Right Now?

Before you consider Uniphar, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.

While Uniphar currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines